TowerBrook and CD&R Acquire R1 RCM for $8.9 Billion

Investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice agreed to acquire all outstanding shares of R1 RCM Inc. in an all-cash transaction valuing the company at approximately $8.9 billion ($14.30 per share). The transaction will take R1 private to support continued investment in its revenue-cycle automation platform and expansion of intelligent automation and generative AI capabilities for healthcare providers.